NERV Annual SG&A
$10.41 M
-$167.90 K-1.59%
31 December 2023
Summary:
As of January 23, 2025, NERV annual selling, general & administrative expenses is $10.41 million, with the most recent change of -$167.90 thousand (-1.59%) on December 31, 2023. During the last 3 years, it has fallen by -$6.88 million (-39.76%). NERV annual SG&A is now -41.30% below its all-time high of $17.74 million, reached on December 31, 2019.NERV Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NERV Quarterly SG&A
$2.48 M
+$61.70 K+2.55%
30 September 2024
Summary:
As of January 23, 2025, NERV quarterly selling, general & administrative expenses is $2.48 million, with the most recent change of +$61.70 thousand (+2.55%) on September 30, 2024. Over the past year, it has dropped by -$156.80 thousand (-5.95%). NERV quarterly SG&A is now -57.99% below its all-time high of $5.90 million, reached on June 30, 2020.NERV Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NERV TTM SG&A
-$1.61 B
-$3.31 M-0.21%
30 September 2024
Summary:
As of January 23, 2025, NERV TTM selling, general & administrative expenses is -$1.61 billion, with the most recent change of -$3.31 million (-0.21%) on September 30, 2024. Over the past year, it has dropped by -$1.62 billion (-16425.69%). NERV TTM SG&A is now -8912.56% below its all-time high of $18.54 million, reached on June 30, 2020.NERV TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NERV Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1.6% | -6.0% | -10000.0% |
| 3 y3 years | -39.8% | -6.0% | -10000.0% |
| 5 y5 years | -38.2% | -6.0% | -10000.0% |
NERV Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -21.9% | at low | -18.2% | +31.9% | -29.0% | at low |
| 5 y | 5-year | -41.3% | at low | -58.0% | +31.9% | -58.0% | at low |
| alltime | all time | -41.3% | +910.4% | -58.0% | +1823.0% | -8912.6% | at low |
Minerva Neurosciences Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.48 M(+2.6%) | $9.86 M(-1.6%) |
| June 2024 | - | $2.42 M(-3.9%) | $10.02 M(-2.1%) |
| Mar 2024 | - | $2.51 M(+2.6%) | $10.23 M(-1.7%) |
| Dec 2023 | $10.41 M(-1.6%) | $2.45 M(-7.0%) | $10.41 M(+5.8%) |
| Sept 2023 | - | $2.64 M(+0.1%) | $9.84 M(-2.0%) |
| June 2023 | - | $2.63 M(-2.3%) | $10.05 M(-2.0%) |
| Mar 2023 | - | $2.69 M(+43.4%) | $10.25 M(-3.2%) |
| Dec 2022 | $10.58 M(-20.6%) | $1.88 M(-33.8%) | $10.58 M(-6.6%) |
| Sept 2022 | - | $2.84 M(+0.2%) | $11.33 M(-1.4%) |
| June 2022 | - | $2.83 M(-6.5%) | $11.50 M(-5.0%) |
| Mar 2022 | - | $3.03 M(+15.2%) | $12.11 M(-9.1%) |
| Dec 2021 | $13.33 M(-22.9%) | $2.63 M(-12.4%) | $13.33 M(-7.7%) |
| Sept 2021 | - | $3.00 M(-12.7%) | $14.44 M(-3.0%) |
| June 2021 | - | $3.44 M(-19.0%) | $14.89 M(-14.2%) |
| Mar 2021 | - | $4.25 M(+13.4%) | $17.35 M(+0.3%) |
| Dec 2020 | $17.29 M(-2.5%) | $3.75 M(+8.6%) | $17.29 M(-0.5%) |
| Sept 2020 | - | $3.45 M(-41.5%) | $17.38 M(-6.2%) |
| June 2020 | - | $5.90 M(+40.9%) | $18.54 M(+7.6%) |
| Mar 2020 | - | $4.19 M(+9.0%) | $17.22 M(-2.9%) |
| Dec 2019 | $17.74 M(+5.3%) | $3.84 M(-16.6%) | $17.74 M(-4.2%) |
| Sept 2019 | - | $4.61 M(+0.5%) | $18.52 M(+3.1%) |
| June 2019 | - | $4.58 M(-2.6%) | $17.96 M(+4.1%) |
| Mar 2019 | - | $4.71 M(+1.9%) | $17.25 M(+2.4%) |
| Dec 2018 | $16.84 M | $4.62 M(+13.9%) | $16.84 M(+10.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | $4.05 M(+4.7%) | $15.21 M(+11.8%) |
| June 2018 | - | $3.87 M(-9.8%) | $13.61 M(+10.3%) |
| Mar 2018 | - | $4.29 M(+43.6%) | $12.34 M(+13.0%) |
| Dec 2017 | $10.91 M(+11.9%) | $2.99 M(+22.1%) | $10.91 M(+2.4%) |
| Sept 2017 | - | $2.45 M(-5.8%) | $10.66 M(+0.7%) |
| June 2017 | - | $2.60 M(-9.4%) | $10.59 M(+3.4%) |
| Mar 2017 | - | $2.87 M(+4.8%) | $10.24 M(+5.0%) |
| Dec 2016 | $9.75 M(+28.7%) | $2.74 M(+15.1%) | $9.75 M(+9.0%) |
| Sept 2016 | - | $2.38 M(+5.8%) | $8.95 M(+6.0%) |
| June 2016 | - | $2.25 M(-5.5%) | $8.44 M(+5.0%) |
| Mar 2016 | - | $2.38 M(+23.1%) | $8.04 M(+6.1%) |
| Dec 2015 | $7.58 M(-36.7%) | $1.93 M(+3.1%) | $7.58 M(-25.1%) |
| Sept 2015 | - | $1.88 M(+1.6%) | $10.12 M(-5.0%) |
| June 2015 | - | $1.85 M(-3.6%) | $10.66 M(-10.5%) |
| Mar 2015 | - | $1.92 M(-57.2%) | $11.90 M(-1.0%) |
| Dec 2014 | $11.96 M(+385.0%) | $4.48 M(+85.5%) | $12.02 M(+27.6%) |
| Sept 2014 | - | $2.41 M(-22.0%) | $9.42 M(+29.1%) |
| June 2014 | - | $3.10 M(+51.9%) | $7.30 M(+68.4%) |
| Mar 2014 | - | $2.04 M(+8.5%) | $4.34 M(+75.8%) |
| Dec 2013 | $2.47 M(+139.3%) | $1.88 M(+543.7%) | $2.47 M(+319.4%) |
| Sept 2013 | - | $291.80 K(+126.4%) | $588.10 K(+98.5%) |
| June 2013 | - | $128.90 K(-23.0%) | $296.30 K(+77.0%) |
| Mar 2013 | - | $167.40 K | $167.40 K |
| Dec 2012 | $1.03 M | - | - |
FAQ
- What is Minerva Neurosciences annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Minerva Neurosciences?
- What is Minerva Neurosciences annual SG&A year-on-year change?
- What is Minerva Neurosciences quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Minerva Neurosciences?
- What is Minerva Neurosciences quarterly SG&A year-on-year change?
- What is Minerva Neurosciences TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Minerva Neurosciences?
- What is Minerva Neurosciences TTM SG&A year-on-year change?
What is Minerva Neurosciences annual selling, general & administrative expenses?
The current annual SG&A of NERV is $10.41 M
What is the all time high annual SG&A for Minerva Neurosciences?
Minerva Neurosciences all-time high annual selling, general & administrative expenses is $17.74 M
What is Minerva Neurosciences annual SG&A year-on-year change?
Over the past year, NERV annual selling, general & administrative expenses has changed by -$167.90 K (-1.59%)
What is Minerva Neurosciences quarterly selling, general & administrative expenses?
The current quarterly SG&A of NERV is $2.48 M
What is the all time high quarterly SG&A for Minerva Neurosciences?
Minerva Neurosciences all-time high quarterly selling, general & administrative expenses is $5.90 M
What is Minerva Neurosciences quarterly SG&A year-on-year change?
Over the past year, NERV quarterly selling, general & administrative expenses has changed by -$156.80 K (-5.95%)
What is Minerva Neurosciences TTM selling, general & administrative expenses?
The current TTM SG&A of NERV is -$1.61 B
What is the all time high TTM SG&A for Minerva Neurosciences?
Minerva Neurosciences all-time high TTM selling, general & administrative expenses is $18.54 M
What is Minerva Neurosciences TTM SG&A year-on-year change?
Over the past year, NERV TTM selling, general & administrative expenses has changed by -$1.62 B (-16425.69%)